These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 6089145

  • 1. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G, Hsiao S, Itoh S.
    Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice.
    Suh HH, Tseng LF.
    Eur J Pharmacol; 1990 Apr 25; 179(3):329-38. PubMed ID: 2142090
    [Abstract] [Full Text] [Related]

  • 3. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN, Stivers JA, Hommer DW, Skirboll LR, Paul SM.
    J Pharmacol Exp Ther; 1986 Feb 25; 236(2):320-30. PubMed ID: 3003339
    [Abstract] [Full Text] [Related]

  • 4. Differential antagonism by proglumide of various CCK-mediated effects in mice.
    Barbaz BS, Autry WL, Ambrose FG, Gerber R, Liebman JM.
    Prog Clin Biol Res; 1985 Feb 25; 192():151-8. PubMed ID: 4080708
    [Abstract] [Full Text] [Related]

  • 5. [The effect of cholecystokinin antagonists on satiety induced by cholecystokinin octapeptide in dogs].
    Sakatani N, Inui A, Baba S.
    Nihon Naibunpi Gakkai Zasshi; 1989 Oct 20; 65(10):1149-58. PubMed ID: 2591604
    [Abstract] [Full Text] [Related]

  • 6. Cholecystokinin octapeptide, proglumide, and passive avoidance in rats.
    Deupree D, Hsiao S.
    Peptides; 1987 Oct 20; 8(1):25-8. PubMed ID: 3575151
    [Abstract] [Full Text] [Related]

  • 7. Cholecystokinin octapeptide, proglumide, and conditioned taste avoidance in rats.
    Deupree D, Hsiao S.
    Physiol Behav; 1987 Oct 20; 41(2):125-8. PubMed ID: 3685161
    [Abstract] [Full Text] [Related]

  • 8. Proglumide has access to brain and antagonizes the central satiety effect of cholecystokinin octapeptide in the dog.
    Inui A, Inoue T, Sakatani N, Oya M, Morioka H, Baba S.
    Brain Res; 1987 Aug 11; 417(2):355-9. PubMed ID: 3651819
    [Abstract] [Full Text] [Related]

  • 9. Unsulfated CCK-8 not blocked by proglumide or CR 1409 in the mouse abdominal irritant-induced stretching assay: possible central site of action.
    Ambrose FG, Barbaz BS, Autry WL, Browne RG, Liebman JM.
    Peptides; 1989 Aug 11; 10(1):31-4. PubMed ID: 2748423
    [Abstract] [Full Text] [Related]

  • 10. Effect of proglumide on rat pancreatic growth.
    Yamaguchi T, Tabata K, Johnson LR.
    Am J Physiol; 1985 Aug 11; 249(2 Pt 1):G294-8. PubMed ID: 2411150
    [Abstract] [Full Text] [Related]

  • 11. The effects of the cholecystokinin antagonist, proglumide, on gonadotropin release in the rat.
    Vijayan E, McCann SM.
    Brain Res Bull; 1986 Apr 11; 16(4):533-6. PubMed ID: 3087585
    [Abstract] [Full Text] [Related]

  • 12. The effects of the cholecystokinin antagonist, proglumide, on prolactin secretion in the rat.
    Vijayan E, McCann SM.
    Life Sci; 1987 Feb 16; 40(7):629-34. PubMed ID: 3807652
    [Abstract] [Full Text] [Related]

  • 13. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
    Katsuura G, Itoh S.
    Peptides; 1986 Feb 16; 7(1):105-10. PubMed ID: 3714527
    [Abstract] [Full Text] [Related]

  • 14. Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats.
    Makovec F, Bani M, Chistè R, Revel L, Rovati LC, Setnikar I.
    Regul Pept; 1986 Dec 30; 16(3-4):281-90. PubMed ID: 3562900
    [Abstract] [Full Text] [Related]

  • 15. Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-maze.
    Vasar E, Lang A, Harro J, Bourin M, Bradwejn J.
    Neuropharmacology; 1994 Jun 30; 33(6):729-35. PubMed ID: 7936110
    [Abstract] [Full Text] [Related]

  • 16. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
    Tanimoto K, Tamminga CA, Chase TN, Nilaver G.
    Endocrinology; 1987 Jul 30; 121(1):127-32. PubMed ID: 3297634
    [Abstract] [Full Text] [Related]

  • 17. The effect of centrally administered CCK-receptor antagonists on food intake in rats.
    Corp ES, Curcio M, Gibbs J, Smith GP.
    Physiol Behav; 1997 Jun 30; 61(6):823-7. PubMed ID: 9177553
    [Abstract] [Full Text] [Related]

  • 18. Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin.
    Khosla S, Crawley JN.
    Life Sci; 1988 Jun 30; 42(2):153-9. PubMed ID: 3336275
    [Abstract] [Full Text] [Related]

  • 19. Proglumide fails to increase food intake after an ingested preload.
    Schneider LH, Gibbs J, Smith GP.
    Peptides; 1986 Jun 30; 7(1):135-40. PubMed ID: 3714531
    [Abstract] [Full Text] [Related]

  • 20. Intracerebroventricular injections of cholecystokinin octapeptide suppress feeding in rats--pharmacological characterization of this action.
    Schick RR, Yaksh TL, Go VL.
    Regul Pept; 1986 Jul 30; 14(4):277-91. PubMed ID: 3749526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.